MNH: Orthosis, Spondylolisthesis Spinal Fixation

Product code MNH, “Orthosis, Spondylolisthesis Spinal Fixation” in FDA's classification database, is a Class II device type under 21 CFR 888.3070 (thoracolumbosacral pedicle screw system), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 309 clearances under MNH, 64 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
MNH
Regulation
21 CFR 888.3070
Class
II
Panel
Orthopedic
Clearances
309
Most recent
Dec 2, 2016
Third-party review
Not eligible
Implant
Yes

What it covers

(1) Rigid pedicle screw systems are comprised of multiple components, made from a variety of materials that allow the surgeon to build an implant system to fit the patient's anatomical and physiological requirements. Such a spinal implant assembly consists of a combination of screws, longitudinal members (e.g., plates, rods including dual diameter rods, plate/rod combinations), transverse or cross connectors, and interconnection mechanisms (e.g., rod-to-rod connectors, offset connectors).

(2) Semi-rigid systems are defined as systems that contain one or more of the following features (including but not limited to): Non-uniform longitudinal elements, or features that allow more motion or flexibility compared to rigid systems.

The identification in 21 CFR 888.3070, thoracolumbosacral pedicle screw system. FDA gives MNH no definition of its own, so the regulation’s describes it.

FDA flags MNH devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K162066Reliance Spinal Screw SystemReliance Medical Systems, LLCDec 2, 2016Traditional
K162801CastleLoc Spinal Fixation SystemL&K BIOMED Co., Ltd.Nov 3, 2016Special
K162143FixxSure® X-LinkInnovasis, Inc.Sep 23, 2016Traditional
K161151Spinal fixation systemCanwell Medical Co., Ltd.Sep 21, 2016Traditional
K162189ANAX™ 5.5 Spinal SystemU&I CorporationAug 30, 2016Special
K151362HC Spinal SystemHung Chun Bio-S Co., Ltd.May 5, 2016Traditional
K153404Zavation Spinal SystemZavation, LLCApr 21, 2016Traditional
K160020Captiva Spine and CapLOX II/TowerLOX Pedicle Screw SystemCaptiva SpineMar 2, 2016Special
K143013Spinal Inner Fixation SystemChangzhou Dingjian Medical Appliance Co., Ltd.Dec 11, 2015Traditional
K151695Romeo posterior osteosynthesis systemSpineartSep 10, 2015Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 309 with a free account)

Clearances by year

64 MNH 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2016893
20151099
201412140
201310124
2012793
201117171

Who submits

51 applicants cleared a MNH device since 2011. 66% of the clearances went to applicants in United States, then China (13%), South Korea (9%) and Switzerland (5%). By type: Traditional 70% and Special 30%.

ApplicantClearances since 2011
U&I Corporation4
Captiva Spine3
Spineart3
Spinefrontier, Inc.3
Kalitec Direct, LLC2
L&K BIOMED Co., Ltd.2
Solco Biomedical Co., Ltd.2
Suzhou Kangli Orthopaedics Instrument Co., Ltd.2

How FDA classifies it

(1) Class II (special controls), when intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative spondylolisthesis with objective evidence of neurologic impairment; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). These pedicle screw spinal systems must comply with the following special controls:

(i) Compliance with material standards;

(ii) Compliance with mechanical testing standards;

(iii) Compliance with biocompatibility standards; and

(iv) Labeling that contains these two statements in addition to other appropriate labeling information:

“Warning: The safety and effectiveness of pedicle screw spinal systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. These conditions are significant mechanical instability or deformity of the thoracic, lumbar, and sacral spine secondary to severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra, degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). The safety and effectiveness of these devices for any other conditions are unknown.”

“Precaution: The implantation of pedicle screw spinal systems should be performed only by experienced spinal surgeons with specific training in the use of this pedicle screw spinal system because this is a technically demanding procedure presenting a risk of serious injury to the patient.”

(2) Class II (special controls), when a rigid pedicle screw system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion in the treatment of degenerative disc disease and spondylolisthesis other than either severe spondylolisthesis (grades 3 and 4) at L5-S1 or degenerative spondylolisthesis with objective evidence of neurologic impairment. These pedicle screw systems must comply with the following special controls:

(i) The design characteristics of the device, including engineering schematics, must ensure that the geometry and material composition are consistent with the intended use.

(ii) Non-clinical performance testing must demonstrate the mechanical function and durability of the implant.

(iii) Device components must be demonstrated to be biocompatible.

(iv) Validation testing must demonstrate the cleanliness and sterility of, or the ability to clean and sterilize, the device components and device-specific instruments.

(v) Labeling must include the following:

(A) A clear description of the technological features of the device including identification of device materials and the principles of device operation;

(B) Intended use and indications for use, including levels of fixation;

(C) Identification of magnetic resonance (MR) compatibility status;

(D) Cleaning and sterilization instructions for devices and instruments that are provided non-sterile to the end user; and

(E) Detailed instructions of each surgical step, including device removal.

(3) Class II (special controls), when a semi-rigid system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion for any indication. In addition to complying with the special controls in paragraphs (b)(2)(i) through (v) of this section, these pedicle screw systems must comply with the following special controls:

(i) Demonstration that clinical performance characteristics of the device support the intended use of the product, including assessment of fusion compared to a clinically acceptable fusion rate.

(ii) Semi-rigid systems marketed prior to the effective date of this reclassification must submit an amendment to their previously cleared premarket notification (510(k)) demonstrating compliance with the special controls in paragraphs (b)(2)(i) through (v) and paragraph (b)(3)(i) of this section.

From 21 CFR 888.3070. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 888.3070 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MNH clearances declared.

Ask about MNH

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about MNH

What is FDA product code MNH?

Product code MNH, “Orthosis, Spondylolisthesis Spinal Fixation” in FDA's classification database, is a Class II device type under 21 CFR 888.3070 (thoracolumbosacral pedicle screw system), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 309 clearances under MNH, 64 of them since 2011.

How many 510(k) clearances are there under MNH?

FDA’s 510(k) database listed 309 clearances under MNH as of Oct 29, 2026, 64 of them decided since 2011; the most recent decision was Dec 2, 2016. The Predicate Finder searches the live database.

Which companies have the most MNH clearances?

Since 2011: U&I Corporation (4), Captiva Spine (3), Spineart (3), Spinefrontier, Inc. (3) and Kalitec Direct, LLC (2). 51 applicants have cleared a MNH device in that time.

Sources

  1. FDA product classification: MNH · Product Classification database
  2. 21 CFR 888.3070: Thoracolumbosacral pedicle screw system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for MNH · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow MNHGet an email when FDA clears, recalls or publishes guidance for MNH devices.

Know what FDA already cleared.